301206 三元生物
已收盘 05-07 15:00:00
资讯
新帖
简况
5月7日三元生物现1笔大宗交易 机构净买入1109.6万元
证券之星 · 09:11
5月7日三元生物现1笔大宗交易 机构净买入1109.6万元
三元生物5月7日现1笔大宗交易 成交金额1109.6万元
新浪证券-红岸工作室 · 09:00
三元生物5月7日现1笔大宗交易 成交金额1109.6万元
三元生物（301206）2025年一季报简析：净利润增2.75%，盈利能力上升
证券之星 · 04-29
三元生物（301206）2025年一季报简析：净利润增2.75%，盈利能力上升
图解三元生物一季报：第一季度单季净利润同比增2.75%
证券之星 · 04-28
图解三元生物一季报：第一季度单季净利润同比增2.75%
图解三元生物年报：第四季度单季净利润同比增67.34%
证券之星 · 04-28
图解三元生物年报：第四季度单季净利润同比增67.34%
4月24日三元生物现1笔大宗交易 机构净买入1429万元
证券之星 · 04-24
4月24日三元生物现1笔大宗交易 机构净买入1429万元
三元生物4月24日现1笔大宗交易 成交金额1429万元
新浪证券-红岸工作室 · 04-24
三元生物4月24日现1笔大宗交易 成交金额1429万元
三元生物：公司赤藓糖醇老产线升级改造项目正按计划推进
证券之星 · 04-23
三元生物：公司赤藓糖醇老产线升级改造项目正按计划推进
三元生物：公司高度重视光伏项目的工程质量与全生命周期风险管理
证券 · 04-21
三元生物：公司高度重视光伏项目的工程质量与全生命周期风险管理
4月21日三元生物现548万元大宗交易
证券之星 · 04-21
4月21日三元生物现548万元大宗交易
三元生物4月21日现1笔大宗交易 成交金额548万元
新浪证券-红岸工作室 · 04-21
三元生物4月21日现1笔大宗交易 成交金额548万元
每周股票复盘：三元生物（301206）大宗交易机构净买入1130万元
证券之星 · 04-18
每周股票复盘：三元生物（301206）大宗交易机构净买入1130万元
三元生物4月14日现1笔大宗交易 成交金额1130万元
新浪证券-红岸工作室 · 04-14
三元生物4月14日现1笔大宗交易 成交金额1130万元
三元生物：目前赤藓糖醇的主流工艺为微生物发酵法，具有工艺成熟、成本可控、适合规模化生产等优势
证券之星 · 04-14
三元生物：目前赤藓糖醇的主流工艺为微生物发酵法，具有工艺成熟、成本可控、适合规模化生产等优势
三元生物：将继续优化与现制茶饮客户等的战略合作推动产品认知提升
证券之星 · 03-07
三元生物：将继续优化与现制茶饮客户等的战略合作推动产品认知提升
三元生物：公司采用自主研发技术生产阿洛酮糖，并非使用日本松谷化学授权专利
证券之星 · 03-07
三元生物：公司采用自主研发技术生产阿洛酮糖，并非使用日本松谷化学授权专利
三元生物：2024年三季报中一年内到期非流动资产主要是大额存单，大部分已经到期
证券之星 · 03-07
三元生物：2024年三季报中一年内到期非流动资产主要是大额存单，大部分已经到期
三元生物：资本市场对饮料及快消品行业的青睐反映市场潜力认可
证券之星 · 03-07
三元生物：资本市场对饮料及快消品行业的青睐反映市场潜力认可
三元生物：公司将进一步加强财务法务证券等方面的专业能力建设
证券之星 · 03-07
三元生物：公司将进一步加强财务法务证券等方面的专业能力建设
公司概况
公司名称：
山东三元生物科技股份有限公司
所属行业：
食品制造业
上市日期：
2022-02-10
主营业务：
山东三元生物科技股份有限公司主营业务是功能糖赤藓糖醇和阿洛酮糖产品的研发、生产和销售。公司的主要产品是赤藓糖醇及复配糖、阿洛酮糖。公司主要产品赤藓糖醇生产能力为13.5万吨，是目前全球规模最大的赤藓糖醇生产企业，在赤藓糖醇行业内具有良好的口碑和较强的品牌优势，公司生产的天绿原牌赤藓糖醇被评为“山东优质品牌”和“山东知名品牌”。
发行价格：
109.30
{"stockData":{"symbol":"301206","market":"SZ","secType":"STK","nameCN":"三元生物","latestPrice":28.02,"timestamp":1746601428000,"preClose":26.66,"halted":0,"volume":7385046,"delay":0,"changeRate":0.051,"floatShares":108000000,"shares":202000000,"eps":0.5221,"marketStatus":"已收盘","change":1.36,"latestTime":"05-07 15:00:00","open":26.66,"high":28.33,"low":26.66,"amount":204000000,"amplitude":0.0626,"askPrice":28.03,"askSize":38,"bidPrice":28.02,"bidSize":91,"shortable":0,"etf":0,"ttmEps":0.5221,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1746667800000},"marketStatusCode":5,"adr":0,"adjPreClose":26.66,"symbolType":"stock","openAndCloseTimeList":[[1746581400000,1746588600000],[1746594000000,1746601200000]],"highLimit":29.33,"lowLimit":23.99,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":202325700,"isCdr":false,"pbRate":1.2,"roa":"--","peRate":53.66788,"roe":"0.55%","epsLYR":0.52,"committee":0.639735,"marketValue":5669000000,"turnoverRate":0.0686,"status":0,"floatMarketCap":3015000000},"requestUrl":"/m/hq/s/301206/tweets","defaultTab":"tweets","newsList":[{"id":"2533767244","title":"5月7日三元生物现1笔大宗交易 机构净买入1109.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533767244","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533767244?lang=zh_cn&edition=full","pubTime":"2025-05-07 17:11","pubTimestamp":1746609118,"startTime":"0","endTime":"0","summary":"证券之星消息，5月7日三元生物发生大宗交易，交易数据如下：大宗交易成交价格27.74元，相对当日收盘价折价1%，成交40万股，成交金额1109.6万元，买方营业部为机构专用，卖方营业部为中信建投证券股份有限公司淄博政通路证券营业部。近三个月该股共发生5笔大宗交易，合计成交1.75万手，折价成交5笔。截至2025年5月7日收盘，三元生物报收于28.02元，上涨5.1%，换手率6.86%，成交量7.39万手，成交额2.04亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050700025928.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"gpt_icon":0},{"id":"2533721846","title":"三元生物5月7日现1笔大宗交易 成交金额1109.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533721846","media":"新浪证券-红岸工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533721846?lang=zh_cn&edition=full","pubTime":"2025-05-07 17:00","pubTimestamp":1746608400,"startTime":"0","endTime":"0","summary":" 5月7日，三元生物收涨5.10%，收盘价为28.02元，发生1笔大宗交易，合计成交量40万股，成交金额1109.6万元。 第1笔成交价格为27.74元，成交40.00万股，成交金额1,109.60万元，溢价率为-1.00%，买方营业部为机构专用，卖方营业部为中信建投证券股份有限公司淄博政通路证券营业部。 进一步统计，近3个月内该股累计发生5笔大宗交易，合计成交金额为4920.85万元。该股近5个交易日累计下跌0.28%，主力资金合计净流出1993.22万元。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2025-05-07/doc-inevttzy1133257.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2531571226","title":"三元生物（301206）2025年一季报简析：净利润增2.75%，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2531571226","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531571226?lang=zh_cn&edition=full","pubTime":"2025-04-30 07:19","pubTimestamp":1745968777,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期三元生物发布2025年一季报。截至本报告期末，公司营业总收入1.5亿元，同比下降21.73%，归母净利润2491.4万元，同比上升2.75%。本报告期三元生物盈利能力上升，毛利率同比增幅101.26%，净利率同比增幅31.15%。然而去年的净利率为14.72%，算上全部成本后，公司产品或服务的附加值高。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025043000009714.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206"],"gpt_icon":0},{"id":"2531925057","title":"图解三元生物一季报：第一季度单季净利润同比增2.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531925057","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531925057?lang=zh_cn&edition=full","pubTime":"2025-04-29 03:55","pubTimestamp":1745870105,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物2025年一季报显示，公司主营收入1.5亿元，同比下降21.73%；归母净利润2491.4万元，同比上升2.75%；扣非净利润2090.42万元，同比下降12.24%；负债率5.45%，投资收益1905.28万元，财务费用-222.43万元，毛利率17.64%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042900001974.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206"],"gpt_icon":0},{"id":"2531259810","title":"图解三元生物年报：第四季度单季净利润同比增67.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531259810","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531259810?lang=zh_cn&edition=full","pubTime":"2025-04-29 02:17","pubTimestamp":1745864238,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物2024年年报显示，公司主营收入7.13亿元，同比上升42.72%；归母净利润1.05亿元，同比上升87.47%；扣非净利润1.02亿元，同比上升87.04%；其中2024年第四季度，公司单季度主营收入1.98亿元，同比上升33.49%；单季度归母净利润2394.42万元，同比上升67.34%；单季度扣非净利润2300.61万元，同比上升64.73%；负债率6.54%，投资收益1.09亿元，财务费用-1002.58万元，毛利率11.11%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042900001093.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206"],"gpt_icon":0},{"id":"2529676180","title":"4月24日三元生物现1笔大宗交易 机构净买入1429万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529676180","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529676180?lang=zh_cn&edition=full","pubTime":"2025-04-24 17:08","pubTimestamp":1745485722,"startTime":"0","endTime":"0","summary":"证券之星消息，4月24日三元生物发生大宗交易，交易数据如下：大宗交易成交价格28.58元，相对当日收盘价折价1%，成交50万股，成交金额1429万元，买方营业部为机构专用，卖方营业部为中信建投证券股份有限公司淄博政通路证券营业部。近三个月该股共发生4笔大宗交易，合计成交1.35万手，折价成交4笔。截至2025年4月24日收盘，三元生物报收于28.87元，上涨4.0%，换手率7.91%，成交量8.51万手，成交额2.43亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042400028707.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2529791196","title":"三元生物4月24日现1笔大宗交易 成交金额1429万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529791196","media":"新浪证券-红岸工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529791196?lang=zh_cn&edition=full","pubTime":"2025-04-24 17:00","pubTimestamp":1745485200,"startTime":"0","endTime":"0","summary":" 4月24日，三元生物收涨4.00%，收盘价为28.87元，发生1笔大宗交易，合计成交量50万股，成交金额1429万元。 第1笔成交价格为28.58元，成交50.00万股，成交金额1,429.00万元，溢价率为-1.00%，买方营业部为机构专用，卖方营业部为中信建投证券股份有限公司淄博政通路证券营业部。 进一步统计，近3个月内该股累计发生4笔大宗交易，合计成交金额为3811.25万元。该股近5个交易日累计上涨1.23%，主力资金合计净流出1663.97万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2025-04-24/doc-ineuhchx2946207.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2529529378","title":"三元生物：公司赤藓糖醇老产线升级改造项目正按计划推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2529529378","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529529378?lang=zh_cn&edition=full","pubTime":"2025-04-23 16:21","pubTimestamp":1745396473,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物(301206)04月23日在投资者关系平台上答复投资者关心的问题。投资者提问：公司的85,000吨项目为现有赤藓糖醇老产线的改造升级工程，完成后具备生产塔格糖等多种新型代糖的能力，有助于提升产线灵活性与产品结构优化。请问进展如何了？什么时候可以投产呀？三元生物回复：投资者您好！公司赤藓糖醇老产线升级改造项目正按计划推进，完成后将具备生产赤藓糖醇、塔格糖、甘露糖醇等多种功能糖的柔性生产能力。具体进展请关注公司后续公告。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042300027725.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"gpt_icon":0},{"id":"2529236383","title":"三元生物：公司高度重视光伏项目的工程质量与全生命周期风险管理","url":"https://stock-news.laohu8.com/highlight/detail?id=2529236383","media":"证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529236383?lang=zh_cn&edition=full","pubTime":"2025-04-21 22:05","pubTimestamp":1745244300,"startTime":"0","endTime":"0","summary":"证券日报网讯三元生物4月21日在互动平台回答投资者提问时表示，公司高度重视光伏项目的工程质量与全生命周期风险管理。项目在设计环节采用了高抗风等级的组件及结构方案，施工过程严格按照国家规范执行，并配套部署了智能化监测系统，持续提升极端天气下的应对能力，确保光伏设施运行的安全与稳定。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-04-21/doc-inetxwtn8470225.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2529827381","title":"4月21日三元生物现548万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2529827381","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529827381?lang=zh_cn&edition=full","pubTime":"2025-04-21 17:09","pubTimestamp":1745226594,"startTime":"0","endTime":"0","summary":"证券之星消息，4月21日三元生物发生大宗交易，交易数据如下：大宗交易成交价格27.4元，相对当日收盘价折价1.01%，成交20万股，成交金额548万元，买方营业部为国海证券股份有限公司山东分公司，卖方营业部为中信建投证券股份有限公司淄博政通路证券营业部。近三个月该股共发生2笔大宗交易，合计成交6000.0手，折价成交2笔。截至2025年4月21日收盘，三元生物报收于27.68元，上涨1.21%，换手率3.12%，成交量3.36万手，成交额9254.27万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042100022279.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2529822096","title":"三元生物4月21日现1笔大宗交易 成交金额548万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529822096","media":"新浪证券-红岸工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529822096?lang=zh_cn&edition=full","pubTime":"2025-04-21 17:00","pubTimestamp":1745226000,"startTime":"0","endTime":"0","summary":" 4月21日，三元生物收涨1.21%，收盘价为27.68元，发生1笔大宗交易，合计成交量20万股，成交金额548万元。 第1笔成交价格为27.40元，成交20.00万股，成交金额548.00万元，溢价率为-1.01%，买方营业部为国海证券股份有限公司山东分公司，卖方营业部为中信建投证券股份有限公司淄博政通路证券营业部。 进一步统计，近3个月内该股累计发生2笔大宗交易，合计成交金额为1678万元。该股近5个交易日累计下跌3.01%，主力资金合计净流出3075.27万元。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2025-04-21/doc-inetxncs8598048.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2528013115","title":"每周股票复盘：三元生物（301206）大宗交易机构净买入1130万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528013115","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528013115?lang=zh_cn&edition=full","pubTime":"2025-04-19 03:11","pubTimestamp":1745003473,"startTime":"0","endTime":"0","summary":"截至2025年4月18日收盘，三元生物（301206）报收于27.35元，较上周的28.62元下跌4.44%。本周，三元生物4月15日盘中最高价报29.46元。4月16日盘中最低价报27.06元。三元生物当前最新总市值55.34亿元，在化学制品板块市值排名53/168，在两市A股市值排名2500/5146。本周关注点交易信息汇总: 4月14日三元生物现1笔大宗交易，机构净买入1130万元交易信息汇总4月14日三元生物现1笔大宗交易，机构净买入1130万元。以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025041900004682.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2527184803","title":"三元生物4月14日现1笔大宗交易 成交金额1130万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527184803","media":"新浪证券-红岸工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527184803?lang=zh_cn&edition=full","pubTime":"2025-04-14 17:00","pubTimestamp":1744621200,"startTime":"0","endTime":"0","summary":" 4月14日，三元生物收跌0.28%，收盘价为28.54元，发生1笔大宗交易，合计成交量40万股，成交金额1130万元。 第1笔成交价格为28.25元，成交40.00万股，成交金额1,130.00万元，溢价率为-1.02%，买方营业部为机构专用，卖方营业部为中信建投证券股份有限公司淄博政通路证券营业部。 进一步统计，近3个月内该股累计发生2笔大宗交易，合计成交金额为2082.06万元。该股近5个交易日累计上涨18.92%，主力资金合计净流入1331.48万元。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2025-04-14/doc-inetcqhp8224580.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2527990177","title":"三元生物：目前赤藓糖醇的主流工艺为微生物发酵法，具有工艺成熟、成本可控、适合规模化生产等优势","url":"https://stock-news.laohu8.com/highlight/detail?id=2527990177","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527990177?lang=zh_cn&edition=full","pubTime":"2025-04-14 16:06","pubTimestamp":1744617968,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物04月14日在投资者关系平台上答复投资者关心的问题。可以拿赤藓糖醇举例说明一下吗？目前赤藓糖醇的主流工艺为微生物发酵法，具有工艺成熟、成本可控、适合规模化生产等优势。酶法合成和全细胞催化受限于酶制剂成本高、工艺复杂，暂主要应用于高附加值产品。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025041400019534.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2517746151","title":"三元生物：将继续优化与现制茶饮客户等的战略合作推动产品认知提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2517746151","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517746151?lang=zh_cn&edition=full","pubTime":"2025-03-07 15:57","pubTimestamp":1741334265,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物03月07日在投资者关系平台上答复投资者关心的问题。共同投资建厂也罢，只要能成功可以更加打响公司品牌。公司高度重视新型功能糖在消费市场的推广与普及，未来将继续优化与包括现制茶饮客户在内的合作伙伴和渠道商的战略合作，推动相关产品认知的提升，进一步加深消费者对优质功能糖的认可。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030700023844.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2517217460","title":"三元生物：公司采用自主研发技术生产阿洛酮糖，并非使用日本松谷化学授权专利","url":"https://stock-news.laohu8.com/highlight/detail?id=2517217460","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517217460?lang=zh_cn&edition=full","pubTime":"2025-03-07 15:57","pubTimestamp":1741334258,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物(301206)03月07日在投资者关系平台上答复投资者关心的问题。投资者提问：请问：1、日本松谷化学授权给三元生物用于阿洛酮糖结晶的那专利，会在何时到期失去专利保护？2、该专利大概会提升产品多少成本？3、当前三元使用该专利生产的阿洛酮糖的结晶率是多少？此专利在未来是否有进一步提升阿洛酮糖结晶率的空间？谢谢董秘先生。三元生物回复：投资者您好！公司采用自主研发技术生产阿洛酮糖，并非使用日本松谷化学授权专利。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030700023822.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2517749481","title":"三元生物：2024年三季报中一年内到期非流动资产主要是大额存单，大部分已经到期","url":"https://stock-news.laohu8.com/highlight/detail?id=2517749481","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517749481?lang=zh_cn&edition=full","pubTime":"2025-03-07 15:57","pubTimestamp":1741334246,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物03月07日在投资者关系平台上答复投资者关心的问题。投资者提问：看公司三季报账上有29亿多一年内到期的非流动资产是什么？具体什么时间到期，到期后公司怎么安排这29亿资产三元生物回复：投资者您好！2024年三季报中一年内到期非流动资产主要是大额存单，大部分已经到期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030700023783.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"gpt_icon":0},{"id":"2517117461","title":"三元生物：资本市场对饮料及快消品行业的青睐反映市场潜力认可","url":"https://stock-news.laohu8.com/highlight/detail?id=2517117461","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517117461?lang=zh_cn&edition=full","pubTime":"2025-03-07 15:57","pubTimestamp":1741334232,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物03月07日在投资者关系平台上答复投资者关心的问题。确实，资本市场对饮料及快消品行业的青睐，反映了市场对消费品行业潜力的认可，也为像我们这样具备国际竞争力的原料供应商提供了更多机遇。我们也看到了现制茶饮及相关行业的快速增长，未来我们将加大在这些领域的业务布局，进一步推动功能糖的应用，助力公司在健康饮品和快消品市场的长远发展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030700023744.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2517174982","title":"三元生物：公司将进一步加强财务法务证券等方面的专业能力建设","url":"https://stock-news.laohu8.com/highlight/detail?id=2517174982","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517174982?lang=zh_cn&edition=full","pubTime":"2025-03-07 15:55","pubTimestamp":1741334106,"startTime":"0","endTime":"0","summary":"未来，公司将进一步加强财务、法务、证券等方面的专业能力建设，提升管理团队的规范化运作水平，以更加稳健的发展回馈投资者。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030700023423.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","BK0226","301206"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1746653445350,"stockEarnings":[{"period":"1week","weight":0.0814},{"period":"1month","weight":0.1675},{"period":"3month","weight":0.0911},{"period":"6month","weight":-0.0139},{"period":"1year","weight":-0.0938},{"period":"ytd","weight":0.0798}],"compareEarnings":[{"period":"1week","weight":0.0194},{"period":"1month","weight":0.0795},{"period":"3month","weight":0.022},{"period":"6month","weight":-0.0318},{"period":"1year","weight":0.0619},{"period":"ytd","weight":-0.0027}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"山东三元生物科技股份有限公司","boardCode":"AI0014","boardName":"食品制造业","stockholders":"13930人(较上一季度增加0.56%)","perCapita":"7725股","listingDate":"2022-02-10","address":"山东省滨州市滨城区滨北张富路89号","registeredCapital":"20232万元","survey":" 山东三元生物科技股份有限公司主营业务是功能糖赤藓糖醇和阿洛酮糖产品的研发、生产和销售。公司的主要产品是赤藓糖醇及复配糖、阿洛酮糖。公司主要产品赤藓糖醇生产能力为13.5万吨，是目前全球规模最大的赤藓糖醇生产企业，在赤藓糖醇行业内具有良好的口碑和较强的品牌优势，公司生产的天绿原牌赤藓糖醇被评为“山东优质品牌”和“山东知名品牌”。","listedPrice":109.3},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.3","shortVersion":"4.33.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三元生物(301206)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三元生物(301206)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三元生物,301206,三元生物股票,三元生物股票老虎,三元生物股票老虎国际,三元生物行情,三元生物股票行情,三元生物股价,三元生物股市,三元生物股票价格,三元生物股票交易,三元生物股票购买,三元生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三元生物(301206)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三元生物(301206)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}